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The  Antibiotic-Resistant  Bacteria  Crisis:  Overcoming  Methicillin-Resistant 
Staphylococcus  Aureus  (MRSA)  by  Myxobacterial  Predation 
With  the  growing  threat  of  antibiotic-resistant  bacteria,  the  need  for  finding  new 
antibiotics  is  at  an  all-time  high.  According  to  the  Center  for  Disease  Control  and  Prevention 
(CDC),  there  were  over  2.8  million  cases  of  antibiotic-resistant  infections  in  the  United  States  in 
2019  and  over  35,000  individuals  have  died  from  them.  Methicillin-Resistant  Staphylococcus 
Aureus  (MRSA)  accounts  for  323,700  of  these  cases,  with  10,600  deaths.  MRSA  is  a  common 
cause  of  nosocomial  infections.  Although  antibiotics  are  available  to  treat  MRSA,  such  as 
Vancomycin,  the  possibility  remains  that  these  strains  are  likely  to  develop  a  resistance  to  these 
compounds  as  it  has  done  with  other  antibiotics. 
The  goal  of  this  project  is  to  test  MRSA  against  various  strains  of  Myxobacteria,  to  see  if 
we  can  develop  a  way  for  Myxobacteria  to  succesfully  treat  MRSA  infections.  Myxobacteria  are 
predatory  bacteria  found  in  soil  and  produce  several  antibiotics  such  as  Myxovirescin.  Through 
gliding  motility,  they  are  able  to  move  toward  prey  and  release  enzymes  that  aid  in  predation. 
We  have  done  predation  assays  with  different  Myxobacteria  strains  preying  over  MRSA.  We 
have  also  found  that  our  wild-isolate  strains  of  Myxobacteria  show  enhanced  predatory  behavior 
than  lab  reference  strains.  This  can  be  useful  in  finding  a  more  effective  strain  to  fight  MRSA 
infections. 
Due  to  Myxobacteria’s  unique  predatory  behavior,  this  can  be  a  breakthrough  in  fighting 
antibitoic-resistant  bacteria  as  well  as  possibly  developing  a  Myxobacteria  antibiotic  that  doesn’t 
readily  lend  to  the  development  of  antibiotic  resistance  with  continued  use.  Nosocomial 
infections  have  shown  to  pose  a  threat  in  healthcare  especially  for  immunosuppressed  patients 
in  healthcare  facilities.  This  research  project  aims  to  provide  sufficient  data  and  results  that  can 
help  in  fighting  this  issue,  starting  with  MRSA. 
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